Former SAC Capital exec accused of $276 million insider-trading scheme

U.S. prosecutors have charged Mathew Martoma, a former portfolio manager at CR Intrinsic, a unit of SAC Capital Advisors, with what they say is the largest insider-trading scheme ever charged. They said he received profits and avoided losses, a combination worth more than $276 million, by using information leaked by a doctor relating to clinical trials of an Alzheimer's drug by Elan and Wyeth.

View Full Article in:

New York Times (tiered subscription model), The · · Bloomberg

Published in Brief: